scPharmaceuticals Yönetim
Yönetim kriter kontrolleri 2/4
Şu anda CEO hakkında yeterli bilgiye sahip değiliz.
Anahtar bilgiler
John Tucker
İcra Kurulu Başkanı
US$1.8m
Toplam tazminat
| CEO maaş yüzdesi | 32.8% |
| CEO görev süresi | 7.8yrs |
| CEO sahipliği | 0.2% |
| Yönetim ortalama görev süresi | Veri yok |
| Yönetim Kurulu ortalama görev süresi | 7yrs |
Son yönetim güncellemeleri
Recent updates
Is scPharmaceuticals (NASDAQ:SCPH) Using Too Much Debt?
Jun 27
scPharmaceuticals Inc. (NASDAQ:SCPH) Stocks Shoot Up 26% But Its P/S Still Looks Reasonable
Jun 27The scPharmaceuticals Inc. (NASDAQ:SCPH) Full-Year Results Are Out And Analysts Have Published New Forecasts
Mar 16Is scPharmaceuticals (NASDAQ:SCPH) Using Debt Sensibly?
Nov 25scPharmaceuticals: Furoscix Approval A Potential Paradigm Shift For Heart Failure Patients
Oct 20FDA approves scPharmaceuticals Furoscix to treat congestion in heart failure
Oct 10Does scPharmaceuticals (NASDAQ:SCPH) Have A Healthy Balance Sheet?
Jan 11Is scPharmaceuticals (NASDAQ:SCPH) A Risky Investment?
Sep 02scPharmaceuticals: We Still See A High Probability Of Success For FUROSCIX
Aug 26Here's What scPharmaceuticals Inc.'s (NASDAQ:SCPH) Shareholder Ownership Structure Looks Like
Mar 09How Many scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Do Institutions Own?
Nov 24
CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$61m |
| Mar 31 2024 | n/a | n/a | -US$58m |
| Dec 31 2023 | US$2m | US$604k | -US$55m |
| Sep 30 2023 | n/a | n/a | -US$50m |
| Jun 30 2023 | n/a | n/a | -US$45m |
| Mar 31 2023 | n/a | n/a | -US$40m |
| Dec 31 2022 | US$2m | US$580k | -US$37m |
| Sep 30 2022 | n/a | n/a | -US$35m |
| Jun 30 2022 | n/a | n/a | -US$31m |
| Mar 31 2022 | n/a | n/a | -US$29m |
| Dec 31 2021 | US$2m | US$550k | -US$28m |
| Sep 30 2021 | n/a | n/a | -US$28m |
| Jun 30 2021 | n/a | n/a | -US$31m |
| Mar 31 2021 | n/a | n/a | -US$32m |
| Dec 31 2020 | US$2m | US$531k | -US$32m |
| Sep 30 2020 | n/a | n/a | -US$35m |
| Jun 30 2020 | n/a | n/a | -US$32m |
| Mar 31 2020 | n/a | n/a | -US$31m |
| Dec 31 2019 | US$1m | US$514k | -US$33m |
| Sep 30 2019 | n/a | n/a | -US$27m |
| Jun 30 2019 | n/a | n/a | -US$27m |
| Mar 31 2019 | n/a | n/a | -US$29m |
| Dec 31 2018 | US$1m | US$494k | -US$29m |
| Sep 30 2018 | n/a | n/a | -US$31m |
| Jun 30 2018 | n/a | n/a | -US$31m |
| Mar 31 2018 | n/a | n/a | -US$28m |
| Dec 31 2017 | US$2m | US$380k | -US$24m |
Tazminat ve Piyasa: John 'ın toplam tazminatı ($USD 1.84M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 1.48M ).
Tazminat ve Kazançlar: John şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.
CEO
John Tucker (61 yo)
7.8yrs
Görev süresi
US$1,838,662
Tazminat
Mr. John H. Tucker has been the Chief Executive Officer and President of scPharmaceuticals Inc. (alternate name: scPharmaceuticals LLC) since January 30, 2017 and serves as its Principal Executive Officer...
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| President | 8.8yrs | US$1.84m | 0.18% $ 368.9k | |
| Independent Director | 9.9yrs | US$184.55k | 0.11% $ 221.6k | |
| Independent Chairman of the Board | 8.4yrs | US$227.05k | 0.010% $ 20.3k | |
| Independent Director | 10.7yrs | US$189.55k | 0% $ 0 | |
| Independent Director | 7yrs | US$187.05k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
| Independent Director | 3.8yrs | US$182.05k | 0% $ 0 | |
| Independent Director | 6.3yrs | US$187.05k | 0% $ 0 | |
| Independent Director | 6.4yrs | US$197.05k | 0% $ 0 | |
| Independent Director | 4.3yrs | US$187.05k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
| Member of Scientific Advisory Board | no data | Veri yok | Veri yok |
7.0yrs
Ortalama Görev Süresi
63yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: SCPH 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 7 yıldır).